Emjard M 12.5mg/1000mg (14 Tablet / Pack)

Prescription combination tablet utilized for glycemic control in type 2 diabetes.

PKR 494.00

You save: PKR 0

Quantity:

SKU: EMJARD_M_125MG1000MG_14_TABLET_PACK

Category: Tablets & Capsules

Emjard M 12.5mg/1000mg Tablets are an oral prescription combination therapy indicated for managing glycemic control in type 2 diabetes mellitus. It combines a potent SGLT2 inhibitor with a biguanide to lower hepatic sugar production and promote urinary glucose clearing. This dual-action tablet is highly effective when single-agent metformin therapies fail to sustain baseline target blood sugar markers.

Purpose

Used to improve blood sugar control by reducing glucose absorption and synthesis.

Ingredients

Empagliflozin 12.5mg, Metformin HCl 1000mg

Warnings

High risk of rare but severe metabolic lactic acidosis complications. Contraindicated in patients presenting with severe renal impairment or failure. Temporarily suspend treatment during clinical procedures involving iodinated contrast media. Monitor closely for symptoms of perineal necrotizing fasciitis during use.